NEWS

CRISPR Gene Drives May Not Be As Effective As Once Hoped
Technology Networks
Researchers are exploring the use of the revolutionary gene-editing tool CRISPR-Cas9 to fight human disease and agricultural blight. But a study from Indiana University has found several challenges to the method’s use in saving lives and crops.

CRISPR Gene Drives May Not Be As Effective As Once Hoped
Technology Networks
Researchers are exploring the use of the revolutionary gene-editing tool CRISPR-Cas9 to fight human disease and agricultural blight. But a study from Indiana University has found several challenges to the method’s use in saving lives and crops.

Gene therapy could ‘turn off’ severe allergies
Medical Xpress
“We have now been able ‘wipe’ the memory of these T-cells in animals with gene therapy, de-sensitising the immune system so that it tolerates the protein. “Our work used an experimental asthma allergen, but this research could be applied to treat those …
Allergy treatment: Scientists claim breakthrough that could lead to cure for all intolerancesThe Independent

all 2 news articles »

CRISPR study reporting ‘off-target mutations’ draws skepticism from other researchers
Genetic Literacy Project
A central promise of CRISPR-based gene editing is its ability to pinpoint particular genes. But if this technology produces dangerous side effects by creating unexpected and unwanted mutations across the genome, that could hamper or even derail many of …

Protein Essential for Normal Mammary Stem Cell Function Identified
Technology Networks
When a stem cell differentiates, it starts down a one-way path that will result in its specialization and eventually its death. For instance, a stem cell in the breast can become a luminal cell, one of the breast’s “milk factories.” Such cells have a …

and more »

Protein Essential for Normal Mammary Stem Cell Function Identified
Technology Networks
When a stem cell differentiates, it starts down a one-way path that will result in its specialization and eventually its death. For instance, a stem cell in the breast can become a luminal cell, one of the breast’s “milk factories.” Such cells have a …

Lonza buys Dutch cell and gene therapy CMO
FiercePharma
Loza said with this deal its gene therapy manufacturing network will span Europe, Asia and the U.S. It is Lonza’s U.S. operation in the U.S. that recently ran into FDA concerns. Lonza had its cell therapy facility in Walkersville, Maryland, slapped …